PE/VC investors

Private Equity (PE) and Venture Capital (VC) investors are the catalysts of innovation and growth in the business world. PE firms primarily target established companies, seeking to optimize operations and unlock value through strategic investments and management expertise. They focus on long-term growth and profitability, often preparing businesses for a future sale or IPO. VC investors, by contrast, are the adventurers of finance, injecting capital into high-potential startups and early-stage companies. They embrace risk for the possibility of outsized returns, often becoming invaluable advisors. Both investor types not only bring capital but also strategic guidance, industry connections, and market insights, propelling their portfolio companies towards success.

Investors (6,250)
Investor
Description
More information
Perscitus LLP Perscitus LLP
Perscitus LLP is an independent, London based investment consultant.
View
Persistence Capital Partners Persistence Capital Partners
PCP is a Canadian-based private equity fund exclusively focused on high-growth opportunities in the healthcare field. With our deep industry expertise, PCP aims to create significant long-term capital appreciation by identifying and developing attractive investment opportunities in the healthcare market, with a focus on businesses across a broad spectrum in the healthcare sector. <br /> <br /> Our breadth of knowledge in the healthcare market and extensive M&A experience allows us to rapidly evaluate and act on investment opportunities. As former owners, operators and regulators of healthcare businesses in Canada and globally, we understand the strategic and operational issues business managers are facing. These capabilities uniquely position us as a partner of choice for growth capital, or to provide business owners with full or partial exit opportunities.
View
Persistent Systems Persistent Systems
We build software that drives the business of our customers; enterprises and software product companies with software at the core of their digital transformation.
View
Perusa Fund Perusa Fund
The Fund invests in companies that are confronted with dramatic change. <br /> However, it also takes a share in profitable and easy to manage companies. <br /> <br /> Our investment management companies usually have an annual turnover of about <br /> 30 million up to more than 1 billion euros, with typical dimensions ranging around <br /> 50 and 300 million euros.
View
Perwyn Perwyn
Perwyn is an entrepreneurial, privately-funded investment firm benefiting from an ‘evergreen’ fund structure that brings flexibility and differentiates us from our peers. We seek opportunities to invest in development capital and buy-out situations in businesses valued at £25-125 million. We particularly target opportunities to be the first round of institutional capital and/or to work with founders or entrepreneurs where we share a strong alignment of interest and core values consistent with our family-backed capital. We also provide flexible debt capital solutions for entrepreneurial companies, investing £5-25 million per deal for growth and transitional capital. Our team is a unique combination of private equity professionals, specialist lenders and family-office investors.
View
Perwyn Advisors Perwyn Advisors
Founded in 2013, Perwyn is a family backed, international private and growth equity investor. Perwyn works closely with investee companies applying strategic and operational expertise in addition to providing capital. Perwyn is free from the usual private equity funding cycles, focusing above all on our investments rather than fund raising. We approach investment with an evergreen model and believe in genuine partnership with management teams, seeking to facilitate long term growth and development. There are two main focuses of our business. Perwyn Private Equity is an active lead investor, seeking buyout opportunities in established, growing, cash generative market leaders headquartered in the UK or Western Europe where it can make a material impact on growth and profitability. We invest in businesses with an EV of £/€50-300m, seeking partnership investment support for growth initiatives or transition. Perwyn Growth Capital invests in growing businesses across the same markets, with a passion for backing entrepreneurs and founders on their winning strategy. We seek primarily minority equity investments of £/€5m-50m to help accelerate growth.
View
Peterson Ventures Peterson Ventures
For over 15 years, and across 200 companies, Peterson Partners has partnered with exceptional entrepreneurs. This experience has confirmed for us that people are the key differentiator in success. Entrepreneurial leaders are different from other leaders. They’re the people creating the future, the people so determined to get things done that they make magic. They are the change makers. We back leadership teams who have the grit and passion to build enduring enterprises that make a difference. Partnering with people like this is our dream job. We love nothing more than rolling up our sleeves to help great people build great businesses. We think there is nothing more exciting than helping incredible people build enduring enterprises. We participate for a chapter of growth, usually 5-10 years, during which we work hard as a trusted coach and advisor in building brands, systems, and human capital. People make all the difference, and who we back is our primary investment question. The best part of our work is the lasting relationships we build with incredible entrepreneurs. They inspire us to be better people ourselves, the type you partner with for the long haul. At our core, we believe in paying it forward. There is no such thing as a one-off transaction. We put our companies and their management teams first, so we can achieve more together in the long run. We work hard to earn long term relationships of trust, with many of our entrepreneurs becoming investors and advisers themselves.
View
PetRock Capital PetRock Capital
PetRock Capital is a venture firm that invests in breakthrough blockchain technologies, ranging from ground-breaking Web 3.0 infrastructure to degenerately unorthodox concepts. We adopt an active investment approach and we firmly believe in delivering concrete value to the projects we invest in. Our vision is to build Asia Pacific's leading blockchain fund that maximises value creation.
View
PFH Palladio Holding PFH Palladio Holding
PFH is an independent investment holding, that has operated in Italy for more than 30 years. It has a portfolio of specialized vehicles and provides businesses not only with capital, but also sector expertise. The Group also provides advisory services for extraordinary financial transactions through its subsidiary, Palladio Corporate Finance. Its structure is adaptable, flexible, and elastic, allowing it to approach a wide variety of transactions with the perspective of an advisor or of a direct investor. PFH has a stable capital structure, which blends financial and industrial competencies. The PFH team is solid, cohesive and autonomous, where the managers are also Group partners. Therefore, PFH is not simply a lender, but also a business partner, whose interests are aligned with those of entrepreneurs.
View
Pfizer Ventures Pfizer Ventures
Pfizer Ventures (PV), the venture capital arm of Pfizer Inc., was founded in 2004 and invests for return in areas of current or future strategic interest to Pfizer. PV seeks to remain at the forefront of life science advances, looking to identify and invest in emerging companies that are developing transformative medicines and technologies that have the potential to enhance Pfizer’s pipeline and shape the future of our industry. With a $600M capital commitment from Pfizer for private investments in 2018, PV invests in private companies at all stages of development, with a strong focus on early stage opportunities. Other investments, including start-ups and spinouts, will also be considered. We actively work with our current portfolio companies throughout their growth cycles, contributing strategic guidance in addition to our capital and providing access to internal Pfizer expertise, whenever appropriate. While primarily U.S. focused, international investments may represent up to 20% of the portfolio. We have the ability to lead or join a syndicate of investors and will seek board representation commensurate with our investment. INVESTMENT STRATEGY Primarily focused on potentially transformative therapeutics, with an emphasis on Pfizer's core therapeutic areas (Inflammation & Immunology, Internal Medicine, Oncology, Rare Disease and Vaccines). Focus also includes neuroscience investments, following Pfizer's decision to continue advancing research in this critical area of unmet medical need through a venture capital strategy. Will also consider platform technologies, diagnostics, drug delivery, pharmaceutical services and other technologies that have the potential to transform drug discovery and development. KEY POINTS Active investor, working with management to develop product strategy and build shareholder value. Bring Pfizer pedigree and perspective to our portfolio companies, with the potential to utilize the network and expertise of Pfizer. Streamlined approval process for investment decisions. Potential for Pfizer business development relationship whenever appropriate.
View